Uranium Energy Corp.
UEC
$14.95
-1.32%
Uranium Energy Corp. is a uranium mining company engaged in the exploration, extraction, and processing of uranium and titanium concentrates across projects in the United States, Canada, and Paraguay. The company is a significant North American pure-play uranium producer, distinguished by its operational In-Situ Recovery (ISR) Hub and Spoke platform in Wyoming, which includes two central processing plants and seven U.S. ISR projects. The current investor narrative is intensely focused on the company's positioning within the global nuclear energy renaissance, driven by the secular shift towards carbon-free power and strategic national stockpiling, with recent attention on its ability to ramp up production and capitalize on elevated uranium prices despite recent quarterly financials showing operational losses and revenue volatility.…
UEC
Uranium Energy Corp.
$14.95
UEC 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Uranium Energy Corp.'s 12-month outlook, with a consensus price target around $19.43 and implied upside of +30.0% versus the current price.
Average Target
$19.43
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$12 - $19
Analyst target range
Analyst coverage for UEC is limited, with only 2 analysts providing estimates, which is typical for a small-to-mid-cap resource company and can lead to higher volatility and less efficient price discovery. The available analyst data shows strong bullish sentiment on future fundamentals, with an average EPS estimate of $0.43 and an average revenue estimate of $386.1 million for the coming year, representing a massive projected growth trajectory from recent results. The target price range is not provided in the dataset, but the pattern of recent institutional ratings is unanimously positive, with multiple firms (TD Securities, HC Wainwright, Roth Capital, Goldman Sachs) maintaining or initiating Buy ratings in the last six months, though one downgrade from BMO Capital to 'Market Perform' in September 2025 introduces a note of caution; this overall bullish analyst sentiment, coupled with the wide dispersion between high and low revenue estimates ($184.95M to $568.16M), signals very high conviction in the long-term thesis but also significant uncertainty around the near-term operational execution and commodity price path.
Bulls vs Bears: UEC Investment Factors
The investment debate for UEC is a classic clash between a powerful long-term thematic and severe near-term financial and valuation risks. The bull side currently has stronger narrative momentum, driven by the secular nuclear thesis, analyst conviction, and a robust balance sheet that funds the growth plan. However, the bear side presents overwhelming evidence of current operational failure, with massive losses, negative cash flow, and a valuation that prices in flawless future execution. The single most important tension is between the stratospheric trailing PS ratio of 55.48x and the company's demonstrated inability to generate consistent profits or positive cash flow. The thesis will be resolved by whether UEC can bridge this chasm by delivering the projected $386M in revenue and achieving positive margins, or if the current valuation proves to be speculative excess that will unwind.
Bullish
- Massive Revenue Growth Forecast: Analysts project a staggering revenue surge to an average of $386.1M for the coming year from a recent quarterly base of $20.2M. This anticipated 18x+ growth is the core driver of the investment thesis, reflecting expectations of a successful production ramp-up and strong uranium pricing.
- Strong Balance Sheet & Liquidity: The company has a fortress balance sheet with a current ratio of 8.85 and a negligible debt-to-equity ratio of 0.0023. This is supported by $494M in cash, providing ample runway to fund growth and operations without immediate solvency risk, a critical advantage for a capital-intensive miner.
- Secular Tailwind in Nuclear Energy: UEC is a pure-play on the global nuclear energy renaissance. Its operational ISR platform in North America positions it to benefit from the strategic shift to carbon-free power and national uranium stockpiling, a long-term thematic supporting elevated commodity prices and demand.
- Unanimous Analyst Buy Ratings: Despite limited coverage, the analyst sentiment is overwhelmingly positive, with multiple major firms (Goldman Sachs, Roth Capital, etc.) maintaining Buy ratings. This institutional conviction underscores the long-term strategic value seen in UEC's asset base and market positioning.
Bearish
- Extreme Valuation on Trailing Metrics: The trailing Price-to-Sales ratio of 55.48x is stratospheric and unsustainable for any conventional business. This valuation embeds near-perfect execution of massive future growth, leaving no margin for error and making the stock highly vulnerable to multiple compression.
- Severe Current Financial Losses: The company is deeply unprofitable, with a Q2 net loss of -$13.93M and a gross margin of -76.0%. Trailing twelve-month free cash flow is -$121.85M, indicating it is burning cash to fund operations and growth, reliant on dilutive equity financing.
- Volatile and Inconsistent Revenue: Recent quarterly revenue of $20.2M represents a -59.4% YoY contraction, following a prior quarter of zero revenue. This lumpy, project-based sales cycle creates high earnings volatility and makes near-term financial forecasting exceptionally difficult.
- High Execution & Commodity Price Risk: The bull case hinges entirely on the company successfully ramping production to meet analyst targets of ~$386M in revenue. Any delays in project development, operational issues, or a downturn in uranium prices would catastrophically undermine the growth narrative and valuation.
UEC Technical Analysis
The stock is in a powerful long-term uptrend but has recently entered a corrective phase. The 1-year price change of +196.44% underscores a sustained bull market, with the current price of $14.97 sitting approximately 74% of the way up from its 52-week low of $4.66 towards its high of $20.34; this positioning near the upper third of the range suggests the stock retains significant momentum but is no longer at peak exuberance, having retreated from recent highs. Recent momentum has diverged sharply from the long-term trend, with a 3-month price decline of -16.23% contrasting the massive yearly gain, while the 1-month return of +10.64% indicates a tentative recovery attempt within this short-term downtrend; this divergence signals a healthy consolidation or profit-taking phase after the parabolic move earlier in the year, though the positive relative strength of +3.28% versus the SPY over one month shows it is beginning to outperform again. Key technical support is anchored at the 52-week low of $4.66, though more immediate support lies near the recent March low around $12.09, while resistance is clearly defined at the 52-week high of $20.34; a sustained breakout above $20.34 would signal a resumption of the primary uptrend, whereas a breakdown below the $12 area could indicate a deeper correction. The stock's beta of 1.19 confirms it is 19% more volatile than the broader market, which is typical for a commodity-linked equity and necessitates larger risk buffers for position sizing.
Beta
1.19
1.19x market volatility
Max Drawdown
-40.0%
Largest decline past year
52-Week Range
$5-$20
Price range past year
Annual Return
+188.6%
Cumulative gain past year
| Period | UEC Return | S&P 500 |
|---|---|---|
| 1m | +13.3% | +8.5% |
| 3m | -19.7% | +2.8% |
| 6m | +9.4% | +4.6% |
| 1y | +188.6% | +32.3% |
| ytd | +14.0% | +3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
UEC Fundamental Analysis
Revenue is highly volatile and currently under pressure, with the most recent quarterly revenue of $20.2 million representing a severe year-over-year contraction of -59.4%; this follows a quarter of zero revenue (Q1 2026), indicating an inconsistent and project-based sales cycle typical of a mining company in development and production ramp-up phases, though analyst estimates point to a significant revenue recovery to an average of $386.1 million for the full year. The company is not currently profitable on a net income basis, reporting a Q2 net loss of -$13.93 million and a trailing EPS of -$0.024, while gross margin was deeply negative at -76.0% for the quarter due to high cost of revenue relative to sales; however, the full-year estimated net margin of -1.31% and a forward-looking gross margin of 36.6% suggest the market anticipates a substantial improvement in operational efficiency and pricing realizations as production scales. The balance sheet is exceptionally liquid with a robust current ratio of 8.85 and minimal leverage evidenced by a debt-to-equity ratio of 0.0023, but cash flow generation is a critical concern with trailing twelve-month free cash flow deeply negative at -$121.85 million and operating cash flow for the last quarter at -$38.12 million; this indicates the company is currently funding its growth and operations through external financing, primarily equity issuance, as seen in the $106.09 million from common stock issued in Q2, which dilutes shareholders but maintains a strong cash position of $494.0 million to execute its business plan.
Quarterly Revenue
$20200000.0B
2026-01
Revenue YoY Growth
-0.59%
YoY Comparison
Gross Margin
-0.76%
Latest Quarter
Free Cash Flow
$-121849000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is UEC Overvalued?
Given the company's negative net income and EBITDA, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is extremely elevated at 55.48x, while the forward-looking metric (using analyst revenue estimates) would be substantially lower, implying the market is pricing in a dramatic sales acceleration; the massive gap between trailing and implied forward sales multiples underscores the high-growth, high-expectation narrative embedded in the stock price. Compared to industry averages, specific data is not available in the provided dataset, but a PS ratio of 55x is stratospheric by any conventional measure, indicating a significant premium that can only be justified by expectations of explosive revenue growth, market leadership in a tightening uranium sector, and future margin expansion as projects move from development to steady-state production. Historically, the stock's own valuation has been volatile, with the PS ratio ranging from approximately 34.98x in July 2023 to an extreme of 413.15x as recently as January 2026; the current PS of 55.48x sits well below its recent peak but remains significantly above the lower end of its historical range, suggesting that while some speculative froth has come off, the valuation still embeds very optimistic expectations about the company's future financial performance.
PE
-42.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -171x~659x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-42.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are acute and center on cash burn and execution. The company reported a Q2 operating cash flow of -$38.12M and TTM FCF of -$121.85M, indicating a heavy reliance on external financing, as evidenced by raising $106.09M from stock issuance in Q2. This dilution funds operations but cannot persist indefinitely without revenue scaling. Furthermore, gross margin was -76.0% last quarter, and achieving the forward gross margin of 36.6% is a non-trivial operational leap. Revenue is also highly volatile, with a -59.4% YoY drop last quarter, creating significant earnings unpredictability.
Market & Competitive Risks are dominated by valuation compression. Trading at a trailing PS of 55.48x, UEC carries a massive premium that is wholly dependent on continued euphoria around uranium and flawless execution. A shift in sector sentiment or a broader risk-off move in growth/commodity stocks could trigger severe multiple contraction. The stock's beta of 1.19 confirms its above-market volatility, amplifying downside during market corrections. Competitive risk is moderated by its specialized ISR assets, but the entire sector remains tied to the volatile spot price of uranium, over which UEC has limited control.
The Worst-Case Scenario involves a combination of project execution delays, a sustained decline in uranium prices, and a broader equity market downturn. This would lead to missed revenue targets, sustained cash burn, and a rapid derating of the valuation multiple. The realistic downside could see the stock re-testing its recent March low of ~$12.09, a -19% decline from current levels, or in a more severe scenario, falling towards the $8-$10 range as the growth premium evaporates. From the current price of $14.97, an investor could face a loss of 20-35% in this adverse scenario before longer-term asset value provides a floor.